Loading…
Integra LifeSciences entered a definitive agreement to acquire Acclarent from Ethicon (Johnson & Johnson) for $275 million in cash at closing plus up to $5 million upon regulatory milestones. Acclarent is an ENT device company headquartered in Irvine, California.